87222044 - BASILEA PHARMACEUTICA

Information

• Trademark
• 87222044

• Source

• Serial Number

  87222044

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 01, 2016
  8 years ago

• Transaction Date

  January 04, 2021
  4 years ago

• Status Date

  January 04, 2021
  4 years ago

• Published for Opposition Date

  October 03, 2017
  7 years ago

• Location Date

  May 21, 2019
  5 years ago

• Status Code

  606

• Current Location

  DIVISIONAL UNIT

  Employee Name

  REID, CAILE MAUREEN

• Attorney Name

  Evan A. Raynes

  Law Office Assigned Location Code

  N50

• Owners

  • Basilea Pharmaceutica International AG

Case File Statements

• D10000: "PHARMACEUTICA"
• GS0011: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use
• GS0051: Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions, the treatment of infections and diseases and in the research and development of pharmaceuticals in the treatment of dermatological conditions, the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents for clinical or medical laboratory use (Class 001); Pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Veterinary products and preparations for the treatment and prevention of infections caused by bacteria, and Pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by fungi, viruses, and rheumatoid arthritis; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; Pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical clinical purposes; clinical medical reagents
• GS0421: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Case File Event Statements

• 1/4/2021 - 4 years ago

  41 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 1/4/2021 - 4 years ago

  40 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 5/13/2020 - 4 years ago

  39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/12/2020 - 4 years ago

  38 - EXTENSION 5 GRANTED Type: EX5G

• 4/30/2020 - 4 years ago

  37 - EXTENSION 5 FILED Type: EXT5

• 4/30/2020 - 4 years ago

  36 - TEAS EXTENSION RECEIVED Type: EEXT

• 10/26/2019 - 5 years ago

  35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/24/2019 - 5 years ago

  34 - EXTENSION 4 GRANTED Type: EX4G

• 10/24/2019 - 5 years ago

  33 - EXTENSION 4 FILED Type: EXT4

• 10/24/2019 - 5 years ago

  32 - TEAS EXTENSION RECEIVED Type: EEXT

• 5/29/2019 - 5 years ago

  31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/27/2019 - 5 years ago

  30 - EXTENSION 3 GRANTED Type: EX3G

• 5/27/2019 - 5 years ago

  29 - EXTENSION 3 FILED Type: EXT3

• 5/27/2019 - 5 years ago

  28 - TEAS EXTENSION RECEIVED Type: EEXT

• 5/22/2019 - 5 years ago

  27 - CORRECTED NOA E-MAILED Type: NOAC

• 5/21/2019 - 5 years ago

  26 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 5/3/2019 - 5 years ago

  25 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 5/20/2019 - 5 years ago

  24 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 5/3/2019 - 5 years ago

  23 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD

• 11/2/2018 - 6 years ago

  22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/31/2018 - 6 years ago

  21 - EXTENSION 2 GRANTED Type: EX2G

• 10/31/2018 - 6 years ago

  20 - EXTENSION 2 FILED Type: EXT2

• 10/31/2018 - 6 years ago

  19 - TEAS EXTENSION RECEIVED Type: EEXT

• 5/11/2018 - 6 years ago

  18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/9/2018 - 6 years ago

  17 - EXTENSION 1 GRANTED Type: EX1G

• 5/9/2018 - 6 years ago

  16 - EXTENSION 1 FILED Type: EXT1

• 5/9/2018 - 6 years ago

  15 - TEAS EXTENSION RECEIVED Type: EEXT

• 11/28/2017 - 7 years ago

  14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 10/3/2017 - 7 years ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/3/2017 - 7 years ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/13/2017 - 7 years ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/25/2017 - 7 years ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/11/2017 - 7 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/10/2017 - 7 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/10/2017 - 7 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/10/2017 - 7 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/10/2017 - 7 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/10/2017 - 7 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/8/2017 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 11/4/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 11/4/2016 - 8 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP